Causes and Treatment of Bone Pain of Malignant Origin
- 1 March 1996
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 51 (3) , 383-398
- https://doi.org/10.2165/00003495-199651030-00004
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.Journal of Clinical Oncology, 1993
- Randomised, placebo-controlled multicentre trial of clodronate in multiple myelomaThe Lancet, 1992
- Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.1992
- A double-blind, crossover trial of intravenous clodronate in metastatic bone painJournal of Pain and Symptom Management, 1992
- Morphine intoxication during acute reversible renal insufficiency.1992
- Nonsteroidal Anti-inflammatory Drug Use and Increased Risk for Peptic Ulcer Disease in Elderly PersonsAnnals of Internal Medicine, 1991
- Breakthrough pain: definition, prevalence and characteristicsPAIN®, 1990
- Cancer pain relief and palliative care. Report of a WHO Expert Committee.1990
- Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancerJournal of Pain and Symptom Management, 1989